OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
ASH2L Aggravates Fibrosis and Inflammation through HIPK2 in High Glucose-Induced Glomerular Mesangial Cells
Wen Zhong, Hong Chen, Yejun Dong, et al.
Genes (2022) Vol. 13, Iss. 12, pp. 2244-2244
Open Access | Times Cited: 8
Wen Zhong, Hong Chen, Yejun Dong, et al.
Genes (2022) Vol. 13, Iss. 12, pp. 2244-2244
Open Access | Times Cited: 8
Showing 8 citing articles:
Chinese herbal medicine and its active compounds in attenuating renal injury via regulating autophagy in diabetic kidney disease
Peng Liu, Wenhui Zhu, Yang Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 14
Peng Liu, Wenhui Zhu, Yang Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 14
Functional role of Ash2l in oxLDL induced endothelial dysfunction and atherosclerosis
Zhenghua Su, Jinghuan Wang, Chenxi Xiao, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 5
Zhenghua Su, Jinghuan Wang, Chenxi Xiao, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 5
SOX9: a key transcriptional regulator in organ fibrosis
Yishuo Li, Yue Xing, Ning Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Yishuo Li, Yue Xing, Ning Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Biology and pharmacological inhibition of homeodomain-interacting protein kinases
Adam Štefek, Kamil Paruch
Frontiers in Chemical Biology (2025) Vol. 4
Open Access
Adam Štefek, Kamil Paruch
Frontiers in Chemical Biology (2025) Vol. 4
Open Access
The Sweet Side of HIPK2
Alessia Garufi, Valerio D’Orazi, Giuseppa Pistritto, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2678-2678
Open Access | Times Cited: 4
Alessia Garufi, Valerio D’Orazi, Giuseppa Pistritto, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2678-2678
Open Access | Times Cited: 4
Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review)
Peng Qu, Lanfang Li, Qi Jin, et al.
International Journal of Molecular Medicine (2024) Vol. 54, Iss. 5
Closed Access | Times Cited: 1
Peng Qu, Lanfang Li, Qi Jin, et al.
International Journal of Molecular Medicine (2024) Vol. 54, Iss. 5
Closed Access | Times Cited: 1
ASH2L-mediated H3K4me3 drives diabetic nephropathy through HIPK2 and Notch1 pathway
Wen Zhong, Hong Chen, Yuyu Zhang, et al.
Translational research (2023) Vol. 264, pp. 85-96
Closed Access | Times Cited: 3
Wen Zhong, Hong Chen, Yuyu Zhang, et al.
Translational research (2023) Vol. 264, pp. 85-96
Closed Access | Times Cited: 3
Low dose Taxol ameliorated renal fibrosis in mice with diabetic kidney disease by downregulation of HIPK2
Yang Xia, Hongwei� Jiang, Jinwen Chen, et al.
Life Sciences (2023) Vol. 320, pp. 121540-121540
Closed Access | Times Cited: 2
Yang Xia, Hongwei� Jiang, Jinwen Chen, et al.
Life Sciences (2023) Vol. 320, pp. 121540-121540
Closed Access | Times Cited: 2
